Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies.

Saved in:
Bibliographic Details
Title: Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies.
Authors: de Groot FA; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Dekker TJA; Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands., Doorduijn JK; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Böhringer S; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands; Department of Pharmacology and Toxicology, Leiden University Medical Center, Leiden, the Netherlands., Brink M; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., de Groen RAL; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., de Haan LM; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Woei-A-Jin FJSH; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Noordenbos T; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Sijs-Szabo A; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Oudshoorn MA; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Lam KH; Department of Pathology, Erasmus Medical Center, Rotterdam, the Netherlands., Diepstra A; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Te Boome LCJ; Department of Hematology, Haaglanden Medical Center, Den Haag, the Netherlands., Terpstra V; Department of Pathology, Haaglanden Medical Center, Den Haag, the Netherlands., Bohmer LH; Department of Hematology, Haga Teaching Hospital, Den Haag, the Netherlands., Nicolae A; Department of Pathology, Haga Teaching Hospital, Den Haag, the Netherlands., Posthuma EFM; Department of Internal Medical, Reinier de Graaf Gasthuis, Delft, the Netherlands., Koens L; Department of Pathology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Durian MF; Department of Hematology, Elisabeth-TweeSteden Ziekenhuis Tilburg, Tilburg, the Netherlands., Stavast J; Department of Pathology, Elisabeth-TweeSteden Ziekenhuis Tilburg, Tilburg, the Netherlands., van der Poel MWM; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Hamid MA; Department of Pathology, Maastricht University Medical Center, Maastricht, the Netherlands., Stevens WBC; Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands., van Rooij SLM; Department of Neurology, University Medical Center Utrecht, Utrecht, the Netherlands., Oostvogels RS; Department of Hematology, University Medical Center Utrecht, Utrecht, the Netherlands., Mühlebner A; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Neelis KJ; Department of Radiotherapy, Leiden University Medical Center, Leiden, the Netherlands., van den Brand M; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Tousseyn T; Department of Pathology, University Hospitals Leuven, Leuven, Belgium., Dierickx D; Department of Hematology, University Hospitals Leuven, Leuven, Belgium., de Weerdt O; Department of Internal Medicine, St. Antonius Hospital, Nieuwegein, the Netherlands., Beeker A; Department of Internal Medicine, Spaarne Gasthuis, Haarlem, the Netherlands., Jansen PM; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers Cancer Center Amsterdam and LYMMCARE, Amsterdam, the Netherlands., Zijlstra JM; Department of Hematology, Amsterdam University Medical Centers Cancer Center Amsterdam and LYMMCARE, Amsterdam, the Netherlands., Chamuleau MED; Department of Hematology, Amsterdam University Medical Centers Cancer Center Amsterdam and LYMMCARE, Amsterdam, the Netherlands., Veelken H; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Bromberg JCE; Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands., Nijland M; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: j.s.p.vermaat@lumc.nl.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Dec; Vol. 213, pp. 115068. Date of Electronic Publication: 2024 Oct 13.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0852
DOI:10.1016/j.ejca.2024.115068